Welcome to our dedicated page for Ashland SEC filings (Ticker: ASH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ashland Inc. files regular SEC disclosures that reveal how the company's specialty chemicals business performs across distinct market segments. For specialty chemical manufacturers, segment-level financial breakdowns matter significantly because pharmaceutical ingredients, personal care formulations, and industrial additives operate under different margin structures and market dynamics. The company's 10-K annual reports detail these segment economics, showing which business lines drive profitability and where operational challenges exist.
Investors analyzing Ashland's filings typically focus on several disclosure areas unique to specialty chemicals. Revenue breakdowns by end market reveal exposure to pharmaceutical, personal care, coatings, and construction industries. Geographic revenue splits indicate regional demand patterns and currency exposure. Raw material sourcing discussions highlight supply chain dependencies, particularly important for specialty chemical feedstocks with limited supplier bases. Manufacturing footprint descriptions show facility locations and capacity utilization trends affecting operational efficiency.
Our platform provides AI-powered analysis of Ashland's quarterly 10-Q reports, annual 10-K filings, and proxy statements. When executives file Form 4 insider transaction reports, these appear immediately, letting you track whether leadership buys or sells shares. Material events disclosed through 8-K filings surface operational changes, strategic announcements, and corporate developments between scheduled earnings releases. For a diversified specialty chemicals company like Ashland, these interim disclosures often contain significant operational updates affecting specific business segments.
SEC filings for chemical manufacturers include technical disclosures about environmental compliance, operational safety, and regulatory matters that casual investors might overlook but that carry material financial implications. Our AI summaries highlight these elements, explaining what complex accounting treatments or footnote disclosures mean for segment profitability and cash generation. Access quarterly earnings details without reading 50-page financial statements, and track executive compensation structures through annual proxy filings to understand management incentives.
Ashland Inc. (ASH) reported an equity compensation grant to senior executive Dago Caceres, who serves as SVP & GM, Specialty Additives. On 11/19/2025, Caceres received 4,250 Restricted Stock Units (RSUs), each representing one share of Ashland common stock. These RSUs vest in three equal installments starting one year from the grant date, as long as he remains continuously employed.
On the same date, he was also granted 9,564 Stock Appreciation Rights (SARs) with an exercise price of $50.58 per share under Ashland’s 2021 Omnibus Incentive Compensation Plan. The SARs become exercisable ratably over three years beginning on the first anniversary of the grant and are tied to Ashland common stock. Both awards were issued under shareholder-approved incentive plans and are reported as directly owned.
Ashland Inc. (ASH) reported an equity award for a senior executive. SVP and Chief HRO Eileen Drury received a grant of 3,954 restricted stock units (RSUs) and 8,897 stock appreciation rights (SARs) on November 19, 2025 under Ashland’s shareholder-approved incentive plans.
Each RSU represents one share of Ashland common stock and vests in three equal installments beginning one year from the grant date, as long as she remains continuously employed by the company. The SARs have an exercise price of $50.58 per share, are issued under the 2021 Omnibus Incentive Compensation Plan, and become exercisable ratably over three years starting on the first anniversary of the grant, with an expiration date of November 19, 2035.
Ashland Inc. reported an insider equity award for one of its senior executives. On November 19, 2025, Vice President, Controller and Principal Accounting Officer Samuel Richardson received 1,738 Restricted Stock Units (RSUs), with each RSU representing one share of Ashland common stock. These RSUs were granted under Ashland’s shareholder-approved incentive plan and vest in three equal installments beginning one year from the grant date, as long as he remains continuously employed.
On the same date, Richardson was also granted 3,912 Stock Appreciation Rights (SARs) under the Ashland Inc. 2021 Omnibus Incentive Compensation Plan, with an exercise price of $50.58 per share. The SARs become exercisable ratably over three years starting on the first anniversary of the grant and are tied to 3,912 shares of common stock, with an expiration date of November 19, 2035.
Ashland Inc. (ASH) files its Annual Report, outlining a global additives and specialty ingredients business organized into four segments: Life Sciences, Personal Care, Specialty Additives and Intermediates, plus Unallocated and Other. The company serves consumer and industrial markets in more than 100 countries with about 2,900 employees.
Key growth platforms include cellulosics and polyvinylpyrrolidone products, which each account for significant portions of segment and total consolidated sales. Ashland sold its nutraceuticals business in August 2024, sharpening its Life Sciences focus. As of March 31, 2025, non-affiliate equity market value was approximately $2.7 billion, and 45,718,113 common shares were outstanding as of October 31, 2025.
Environmental matters are significant: at September 30, 2025, Ashland carried $226 million of environmental remediation and related litigation reserves and estimated the upper end of reasonably possible future costs at about $495 million. Environmental remediation expense, net of insurance, was $48 million in 2025, down from $56 million in 2024 and $59 million in 2023. The report also details climate, regulatory, operational and growth risks, alongside extensive human capital, safety and sustainability initiatives.
Ashland Inc. (ASH) Chair and CEO Guillermo Novo, who is also a director, reported equity award activity on 11/17/2025. A block of 6,122 Restricted Stock Units (RSUs) was converted to the same number of shares of common stock, as shown by an option exercise transaction coded "M" at a reference price of $49.6 per share.
To cover tax liabilities from this vesting, 2,563 shares of common stock were withheld and disposed of, coded "F(1)" at $49.6 per share. After these transactions, Novo directly held 140,849 shares of Ashland common stock and indirectly held 31,294 shares through GMGN Novo Family Limited Partnership. The RSU plan is described as shareholder-approved and exempt under Rule 16b-3.
Ashland Inc. (ASH) reported an insider equity transaction by its SVP and Chief HRO, Eileen Drury, on a Form 4. On 11/17/2025, Drury acquired 567 shares of Ashland common stock at $49.60 per share through the vesting and settlement of Restricted Stock Units (transaction code M). In a related move, 280 shares were withheld at $49.60 (transaction code F) to cover tax liabilities tied to the RSU vesting.
After these transactions, Drury directly owned 7,601 shares of Ashland common stock. The RSUs were granted under Ashland’s shareholder-approved incentive plan, and each RSU represents the right to receive one share of common stock upon vesting. The explanation notes that grants under this plan vest in three equal installments beginning one year from the grant date, subject to continued employment.
Ashland Inc. (ASH) senior vice president and CTO Osama M. Musa reported equity transactions involving company stock. On 11/17/2025, 976 Restricted Stock Units were converted to the same number of shares of Ashland common stock at a reference price of $49.6 per share. To cover tax obligations tied to this vesting, 335 shares were withheld, also at $49.6 per share.
Following these transactions, Musa directly owned 29,540 shares of Ashland common stock. The filing notes that each RSU represents the right to receive one share of common stock upon vesting, and that the RSUs were granted under Ashland’s shareholder-approved incentive plan and are exempt under Rule 16b-3.
Ashland Inc. (ASH) senior vice president and CTO Osama M. Musa reported RSU vesting and related tax withholding transactions. On 11/13/2025, 1,393 shares of common stock were acquired through the exercise of restricted stock units at an exercise price of $0, with 477 shares withheld at a market price of $53.10 to cover taxes, leaving 27,525 shares beneficially owned.
On 11/14/2025, 2,091 additional shares were acquired from RSU vesting, with 717 shares withheld at $51.51 for taxes, resulting in 28,899 shares beneficially owned. The RSUs were granted under Ashland’s shareholder-approved incentive plan, vesting in three equal installments, and remaining RSU balances include units accrued in lieu of cash dividends. The report notes it was filed late due to an inadvertent administrative error.
Ashland Inc. (ASH) VP, Controller and PAO Samuel Richardson reported routine equity compensation activity. On 11/17/2025, 107 Restricted Stock Units (RSUs) converted into an equal number of Ashland common shares at an exercise price of $0, shown as transaction code "M." At the same time, 32 shares were disposed of at $49.6 per share under transaction code "F" to cover tax withholding related to the RSU vesting. After these transactions, Richardson beneficially owned 1,072 shares of Ashland common stock directly. The RSUs were granted under Ashland's shareholder-approved incentive plan and are exempt under Rule 16b-3.
Ashland Inc. (ASH) senior executive reports routine equity transactions. The company’s SVP, CFO & PFO filed a Form 4 for activity on 11/17/2025 involving Ashland common stock and restricted stock units (RSUs). A total of 107 shares of common stock were acquired following the vesting and settlement of RSUs at a price of $49.6 per share, and 33 shares were withheld and disposed of at $49.6 per share to cover tax liabilities related to this vesting. After these transactions, the reporting person beneficially owned 2,049 shares of Ashland common stock directly. The RSUs were granted under Ashland’s shareholder-approved incentive plan, and each RSU represents the right to receive one share of common stock upon vesting, generally in three equal installments beginning one year from the grant date, contingent on continued employment.
FAQ
What is the current stock price of Ashland (ASH)?
What is the market cap of Ashland (ASH)?
